RT Journal Article
SR Electronic
T1 Interest of structured reporting and combined automated co-registration and lesion color-coding maps for longitudinal magnetic resonance imaging analysis in patients with multiple sclerosis : the MS-LOBI-SR study protocol
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.02.22276009
DO 10.1101/2022.07.02.22276009
A1 Sébastien Kerdraon
A1 Ichem Mohtarif
A1 Kevin Rose
A1 Douraïed Ben Salem
A1 Brieg Dissaux
A1 Julien Ognard
YR 2022
UL http://medrxiv.org/content/early/2022/07/05/2022.07.02.22276009.abstract
AB MS is characterized by chronic and immune-mediated inflammatory lesions of the brain white matter, disseminated in time and space. As the technology improved over the next three decades, MRI quickly grew to become the single most important paraclinical diagnostic and monitoring tool available. A lesion will be defined as having a high T2/FLAIR signal ≥ 3 millimeters in diameter. The purpose of this study, witch includes 95 patients, was to investigate the benefit of a computer assisted detection reading using combined automated co-registration and lesion color-coding method approach, over a conventional reading approach in follow-up examinations of patients with MS, especially regarding diagnostic accuracy, inter/intra-reader agreement and required reading time. The impact of the use of a structured report on these variables will also be evaluated. The main judgment criteria will be : diagnostic accuracy (effectiveness) to assess the progression-activity of the disease based on the appearance of a T2w-FLAIR hyperintensity or a T1w enhancement on the follow-up examination, compared between consensus corrected CADR and CR readings.The reading of the examinations will be made by radiologists and radiology technician.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comite d'Ethique pour la Recherche en Imagerie Medicale CERIM IRB Number: CRM-2206-271I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesno data available